Want to see IN:BLISSGVS full AI Analyst Report?
Bliss Gvs Pharma Limited (BLISSGVS) Income Statement
Bliss Gvs Pharma Limited Income Statement
Last quarter (Q1 2027), Bliss Gvs Pharma Limited's total revenue was $2.86B, an increase of 37.65% from the same quarter last year. In Q1, Bliss Gvs Pharma Limited's net income was $500.97M. See Bliss Gvs Pharma Limited’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| $ 9.27B | $ 8.10B | $ 7.66B | $ 7.47B | $ 7.38B | |
| $ 5.02B | $ 3.96B | $ 2.49B | $ 3.50B | $ 3.47B | |
| $ 3.71B | $ 1.12B | $ 1.26B | $ 2.52B | $ 2.29B | |
| Depreciation and Amortization | $ 334.83M | $ 294.18M | $ 263.80M | $ 186.73M | $ 173.31M |
| $ 2.35B | $ 1.27B | $ 1.49B | $ 1.35B | $ 762.38M | |
| $ 1.31B | $ 2.84B | $ 1.23B | $ 1.01B | $ 950.22M | |
| $ 590.36M | $ -1.58B | $ -62.28M | $ 53.38M | $ -408.57M | |
| $ 1.90B | $ 1.26B | $ 1.17B | $ 1.06B | $ 541.65M | |
| $ 1.29B | $ 842.99M | $ 754.54M | $ 708.59M | $ 150.40M | |
| Per Share Metrics | |||||
| Basic EPS | $ 12.23 | $ 8.02 | $ 7.23 | $ 6.83 | $ 1.46 |
| Diluted EPS | $ 12.00 | $ 7.95 | $ 7.11 | $ 6.72 | $ 1.43 |
| Weighted Average Shares Outstanding | 105.58M | 106.04M | 104.36M | 103.81M | 103.34M |
| Weighted Average Shares Outstanding (Diluted) | 107.61M | 106.04M | 106.07M | 105.48M | 105.20M |
Currency in INR